Lexeo Therapeutics, Inc. (LXEO): Shares Outstanding

Annual figures by period end, from SEC filings.

73.00M
As of 2025-12-31
78.62M
As of 2026-06-30
+256.8%
3-year compound annual growth
2022-12-31: 1.61M2023-12-31: 26.65M2024-12-31: 33.07M2025-12-31: 73.00M73.00M
2022-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3173.00M+120.7%2026-03-30, Balance as of period end
2024-12-3133.07M+24.1%2026-03-30, Balance as of period end
2023-12-3126.65Mn/m2025-03-24, Balance as of period end
2022-12-311.61Mn/a2024-03-11, Balance as of period end